NORTH CHICAGO, Ill. & SAN CARLOS, Calif. -- -- AbbVie and Alvine Pharmaceuticals, a leader in celiac disease therapeutics development, announced today that they have entered into a global collaboration to develop a novel oral treatment for patients with celiac disease, currently in Phase 2 development.
More...
More...